Cargando…
Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells
Both acute and chronic antibody-mediated allograft rejection (AMR), which are directly mediated by B cells, remain difficult to treat. Long-lived plasma cells (LLPCs) in bone marrow (BM) play a crucial role in the production of the antibodies that induce AMR. However, LLPCs survive through a T cell-...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282180/ https://www.ncbi.nlm.nih.gov/pubmed/34276669 http://dx.doi.org/10.3389/fimmu.2021.682334 |